Ten hypodermic syringes (a-j) with glass barrels, plastic plungers, and metal needles; each syringe has a red plastic needle shield (k-t) protecting the needle; syringes are stored in cardboard trays (u-v) within a cardboard box (y); also found in box were a product information leaflet (w) and inst…
Ten hypodermic syringes (a-j) with glass barrels, plastic plungers, and metal needles; each syringe has a red plastic needle shield (k-t) protecting the needle; syringes are stored in cardboard trays (u-v) within a cardboard box (y); also found in box were a product information leaflet (w) and instruction sheet (x).
Number Of Parts
25
Part Names
a-j - syringes: Length 11.5 cm x Width 1.8 cm x Diameter 1.1 cm
k-t - needle caps: Length 5.0 cm x Width 1.2 cm x Diameter 0.6 cm
u-v - trays: Length 13.5 cm x Width 7.6 cm x Depth 1.4
w - product information leaflet: Length 17.7 cm x Width 10.1 cm
x - instruction sheet: Length 12.6 cm x Width 7.1 cm
y - box: Length 13.7 cm x Width 7.8 cm x Depth 3.8 cm
Printed on syringes (a-j): "INFLUENZA // VIRUS VACCINE, // TRIVALENT, // TYPES A AND B // FLUOGEN® // Exp. 2/10/81 Lot YH598 // PARKE-DAVIS // N 0071-4979-40 // 1/2 ML 1 ML // FOR IM USE";
Printed on leaflet (w): "FLUOGEN® // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // Subvirion Vaccine/Immunizing Antigen, Ether Extracted // DESCRIPTION // [text follows] // ACTION // [text follows] // PARKE-DAVIS // 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continued from Action] // INDICATIONS // [text follows] // 2 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Indications] // CONTRAINDICATIONS // [text follows] // WARNING // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 3 121 887150/C-KF // FLUOGEN // (INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B) // [text continues from Adverse . . .] // DOSAGE AND ADMINISTRATION // [text follows] // STORAGE // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // Unpublished data available upon request. // Issued June 1979 // Parke, Davis & Co/Detroit, Mi 48232 USA 121 887150/C-KF"
Printed on instruction sheet (x): "HOW TO USE THE // Steri-Dose® Syringe // PUSH needle shield and syringe barrel firmly together until two [underlined] clicks are // heard and/or felt. // CLICK No. 1 means the butt end of the double-ended needle has punctured // the diaphragm that separates the needle assembly from the medication. // CLICK No. 2 is made by the flange on the needle assembly striking the hub // of the syringe. Syringe is activated and ready for use. // [above text is repeated in French] // PARKE-DAVIS // Parke, Davis & Co/Detroit, Mi 48232 USA // 41 4079 40 70 1"
Printed on box (y): Top: "ten 0.5 ml Steri-Dose® Syringes DIN 248991 // INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B // Stock 4-4079-510-70 // FLUOGEN® Subvirion Vaccine // 25 g x 3/4" needle // Contains no less than 21 micrograms of HA antigen content per 0.5 ml dose in the recommended ratio of 7µg of HA of the A influenza virus component representative of // A/Brazil/78 (H1N1), 7 µg of HA of the A influenza virus component representative of A/Texas/1/77 (H3N2), and 7µg of HA of the B influenza component // representative of B/Hong Kong/5/72. The vaccine is of chick embryo origin. Standardized according to the NACI and the US PHS requirements for the 1979-80 season. // Dose - Persons 27 years and older, a single injection of 0.5 ml; persons 3 years through 26 years, 2 injections of 0.5 ml, 4 or more weeks apart; persons 6 months through // 35 months, 2 injections of 0.25 ml, 4 or more weeks apart. Inject intramuscularly. See package insert. // Preservative: 0.01% thimerosal (mercury derivative). Polysorbate 80, USP, added during manufacture. // Store at temperature between 2° and 8° C (36° and 46° F). Freezing destroys potency. // Preparing syringe for use – Push needle shield and barrel firmly together until two clicks are heard or felt. // Following removal of the needle shield, the syringe is ready for use. // To prevent re-use of the syringe, re-apply the needle shield and break off needle assembly. Discard entire unit. // U.S. Lic. No. 1. // [above text repeated in French] // Parke, Davis & Co / Detroit, Mi 48232 USA C"; right side: "ten 0.5 ml Steri-Dose syringes // INFLUENZA VIRUS VACCINE, TRIVALENT, TYPES A AND B // FLUOGEN Subvirion Vaccine // 25 g x 34" needle. // Exp date and lot // Feb 10, 1981 YH598 // PARKE-DAVIS // Printed in USA 01 4079 40 70 1 "; front: "CK // NES // BY"
Permanent Location
a-v and y: Storage Room 0010
0010-A3-5
w-x: Storage Room 0010
0010-G Instruction Pamphlets and Measuring Aids Binder pg. 14 a
Condition Remarks
Box is somewhat dirty, dented; trays somewhat dirty; ink fading on some of the syringes; no apparent problems with instruction sheet or leaflet.
Copy Type
Original
Research Facts
This is a vaccine against the influenza virus and is administered intramuscular with a hypodermic syringe.
Exhibit History
On exhibit at City of Ottawa - Public Health L-2016-3 14 Mar 2016 – 31 Dec 2018; extended to 31 Dec 2023